Investor News Archives - Page 2 of 9

Inify Laboratories: Key information regarding Repair Issue

Investor News 2025-12-17

Reference is made to the stock exchange announcement published today, 17 December 2025, regarding the preliminary results of the private placement of new shares (the "Private Placement") in Inify Laboratories […]

Inify Laboratories announces preliminary results of fully guaranteed private placement

Investor News 2025-12-17

STOCKHOLM – 17 December 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the "Company") on 9 December 2025 regarding the fully guaranteed private […]

Inify Laboratories – notification of trade

Investor News, Primary Insider Transactions 2025-12-16

Stockholm, Sweden, December 16, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Fredrik Palm, CEO and primary […]

Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue

Investor News 2025-12-09

STOCKHOLM – 9 December 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the “Company”) on 12 November 2025, regarding a proposed fully guaranteed […]

Bulletin from the extraordinary general meeting of Inify Laboratories AB

Annual General Meeting, Investor News 2025-12-04

Today, December 4, 2025, an extraordinary general meeting was held in INIFY Laboratories AB, reg. no. 559345-4431 (the "Company"). At the meeting, 66,655,976 shares were represented, corresponding to 84.5 per […]

Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue

Investor News 2025-12-03

STOCKHOLM – December 3, 2025 – The board of directors of Inify Laboratories AB ("Inify" or the "Company") announces its intention to postpone the last date of payment in the […]

Inify Laboratories – notice of Extraordinary General Meeting on December 4, 2025

Annual General Meeting, Investor News 2025-11-12

Stockholm – November 12, 2025 – Inify Laboratories AB (publ), a unique laboratory service that provides cancer diagnostics within pathology, hereby invites its shareholders to Extraordinary General Meeting on December […]

Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million

Annual General Meeting, Investor News 2025-11-12

STOCKHOLM – November 12, 2025 – Inify Laboratories AB ("Inify" or the "Company") will in a separate press release call for an extraordinary general meeting (the "EGM") to be held […]

Correction – Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Financial reports, Investor News 2025-10-29

In connection with the publication of the company's Q3 2025 Financial Report, it was discovered that the amount for personnel costs in the parent company's income statement was incorrect. The […]

Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Investor News 2025-10-29

STOCKHOLM – October 29, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, expanded its service offering during the third quarter with the addition of […]

Inify Laboratories: Key information regarding Repair Issue

Inify Laboratories announces preliminary results of fully guaranteed private placement

Inify Laboratories – notification of trade

Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue

Bulletin from the extraordinary general meeting of Inify Laboratories AB

Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue

Inify Laboratories – notice of Extraordinary General Meeting on December 4, 2025

Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million

Correction – Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Our services

Inify Laboratories

For Investors

Contact us

Social media